Skip to main content
Clinical Trials/NCT00680966
NCT00680966
Completed
N/A

Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD

Oregon Research Institute1 site in 1 country180 target enrollmentJanuary 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Adolescent
Sponsor
Oregon Research Institute
Enrollment
180
Locations
1
Primary Endpoint
Children's Depression Rating Scale
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether it is more effective to treat adolescents, with diagnoses of both depression and substance use disorder, with a treatment addressing the substance use first and then treating the depression or to first treat the depression and then treat the substance use or whether treating both disorders simultaneously is most effective.

It is expected that treatment of both disorders at the same time will be the most effective.

Detailed Description

Comorbidity is a well established aspect of adolescent psychopathology. The majority of adolescents entering treatment have more than one condition. This study will evaluate service delivery methods of integrating empirically supported interventions for depression and non-nicotine substance use disorders (SUD)in an effort to improve treatment engagement, response, and maintenance of gains. The two examined interventions are the Adolescent Coping With Depression course (ACWD) and Functional Family Therapy (FFT). This study will expand upon previous research by systematically treating both depression and SUD. Over a 5 year period, 180 adolescents with depression/SUD and their parents/guardians will be recruited in Oregon and New Mexico and randomly assigned to 1 of 3 conditions: (a) FFT followed by ACWD, (b) ACWD followed by FFT, or (c) an intervention combining and augmenting FFT and ACWD (Integrated Treatment). Each treatment arm will consist of 24 sessions provided over 20 weeks. Participants will be assessed at intake, after the provision of 6, 12 (Mid-treatment), 18 and 24 (Post-treatment)treatment sessions, and at 6 and 12 month follow-ups.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
June 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • DSM-IV-TR diagnosis of depression, defined as MDD, dysthymia, or substance-induced mood disorder meeting MDD or dysthymia symptom criteria
  • DSM-IV-TR diagnosis of one or more non-nicotine SUD
  • Some reported illicit drug use in the last 90 days
  • 13-17 years of age
  • parent or guardian willing to participate in study
  • basic English competency (ability to converse in English)

Exclusion Criteria

  • Current and acute suicidal ideation at the level warranting inpatient treatment
  • current psychotic symptoms
  • the adolescent's sibling is already participating in the study
  • if on psychiatric medications, a significant change in dosage levels in the prior 4 weeks -

Outcomes

Primary Outcomes

Children's Depression Rating Scale

Time Frame: Intake, Mid-Treatment, Post, 6 months and 12 months follow-up

Secondary Outcomes

  • Time Life Follow Back(Intake, Mid-Treatment, Post, 6 months and 12 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials